Activation of c-Jun NH2-terminal kinase 3 is mediated by the GluR6·PSD-95·MLK3 signaling module following cerebral ischemia in rat hippocampus

Brain Research

Volumn 1061, Issue 1, 2005, Pages 57-66

  Tian, Hui ^b   Zhang, Quan Guang ^a   Zhu, Guang Xuan ^a   Pei, Dong Sheng ^a   Guan, Qiu Hua ^a   Zhang, Guang Yi ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b JIANGSU NORMAL UNIVERSITY   (China)

Author keywords

c Jun NH2 terminal kinase 3; Cerebral ischemia; Glutamate receptor 6; Kainate receptor; Mixed lineage kinase 3; Postsynaptic density protein 95

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; 6,7,8,9 TETRAHYDRO 5 NITROBENZ[G]INDOLE 2,3 DIONE 3 OXIME; GLUTAMATE RECEPTOR 6; KAINIC ACID RECEPTOR; KETAMINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 12; MIXED LINEAGE KINASE 3; POSTSYNAPTIC DENSITY PROTEIN 95; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVATION; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REPERFUSION;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRAIN ISCHEMIA; ENZYME ACTIVATION; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAP KINASE KINASE KINASES; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 10; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PHOSPHORYLATION; RATS; RECEPTORS, KAINIC ACID; REPERFUSION; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 27444434211     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.09.001     Document Type: Article

References (43)

1. B. Bettler, and C. Mulle AMPA and kainate receptors Neuropharmacology 34 1995 123 139
2. M.H. Cobb MAP kinase pathways Prog. Biophys. Mol. Biol. 71 1999 479 500
3. S.E. Craven, and D.S. Bredt PDZ proteins organize synaptic signaling pathways Cell 93 1998 495 498
4. N.C. Danbolt Glutamate uptake Prog. Neurobiol. 65 2001 1 105
5. S.M. Feller, R. Ren, H. Hanafusa, and D. Baltimore SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl Trends Biochem. Sci. 19 1994 453 458
6. K. Fukunaga, and E. Miyamoto Role of MAP kinase in neurons Mol. Neurobiol. 16 1998 79 95
7. K.A. Gallo, M.R. Mark, D.T. Scadden, Z. Wang, Q. Gu, and P.J. Godowski Identification and characterization of SPRK, a novel src-homology 3 domain-containing proline-rich kinase with serine/threonine kinase activity J. Biol. Chem. 269 1994 15092 15100
8. E.P. Garcia, S. Mehta, L.A. Blair, D.G. Wells, J. Shang, T. Fukushima, J.R. Fallon, C.C. Garner, and J. Marshall SAP90 binds and clusters kainate receptors causing incomplete desensitization Neuron 21 1998 727 739
9. Z. Gu, Q. Jiang, and G. Zhang c-Jun N-terminal kinase activation in hippocampal CA1 region was involved in ischemic injury NeuroReport 12 2001 897 900
10. W. Guo, S. Zou, M. Tal, and K. Ren Activation of spinal kainate receptors after inflammation: behavioral hyperalgesia and subunit gene expression Eur. J. Pharmacol. 452 2002 309 318
11. S. Gupta, T. Barrett, A.J. Whitmarsh, J. Cavanagh, H.K. Sluss, B. Derijard, and R.J. Davis Selective interaction of JNK protein kinase isoforms with transcription factors EMBO J. 15 1996 2760 2770
12. M. Hollmann, and S. Heinemann Cloned glutamate receptors Annu. Rev. Neurosci. 17 1994 31 108
13. T. Honore, S.N. Davies, J. Drejer, E.J. Fletcher, P. Jacobsen, D. Lodge, and F.E. Nielsen Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists Science 241 1988 701 703
14. E.A. Irving, and M. Bamford Role of mitogen- and stress-activated kinases in ischemic injury J. Cereb. Blood Flow Metab. 22 2002 631 647
15. T.H. Johansen, J. Drejer, F. Watjen, and E.O. Nielsen A novel non-NMDA receptor antagonist shows selective displacement of low-affinity [3H] kainate binding Eur. J. Pharmacol. 246 1993 195 204
16. J.M. Lee, G.J. Zipfel, and D.W. Choi The changing landscape of ischaemic brain injury mechanisms Nature 399 1999 A7 A14
17. J. Lerma, A.V. Paternain, J.R. Naranjo, and B. Mellstrom Functional kainate-selective glutamate receptors in cultured hippocampal neurons Proc. Natl. Acad. Sci. U. S. A. 90 1993 11688 11692
18. I.W. Leung, and N. Lassam The kinase activation loop is the key to mixed lineage kinase-3 activation via both autophosphorylation and hematopoietic progenitor kinase 1 phosphorylation J. Biol. Chem. 276 2001 1961 1967
19. +-dependent glutamate transport J. Neurosci. 19 1999 RC16
20. B.J. Mayer, and M.J. Eck SH3 domains. Minding your p's and q's Curr. Biol. 5 1995 364 367
21. M. Migaud, P. Charlesworth, M. Dempster, L.C. Webster, A.M. Watabe, M. Makhinson, Y. He, M.F. Ramsay, R.G. Morris, J.H. Morrison, T.J. O'Dell, and S.G. Grant Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein Nature 396 1998 433 439
22. C. Mulle, A. Sailer, I. Perez-Otano, H. Dickinson-Anson, P.E. Castillo, I. Bureau, C. Maron, F.H. Gage, J.R. Mann, B. Bettler, and S.F. Heinemann Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice Nature 392 1998 601 605
23. T. Nagano, H. Jourdi, and H. Nawa Emerging roles of Dlg-like PDZ proteins in the organization of the NMDA-type glutamatergic synapse J. Biochem. 124 1998 869 875
24. Y. Nishizawa Glutamate release and neuronal damage in ischemia Life Sci. 69 2001 369 381
25. K. Oguro, N. Oguro, T. Kojima, S.Y. Grooms, A. Calderone, X. Zheng, M.V. Bennettn, and R.S. Zukin Knockdown of AMPA receptor GluR2 expression causes delayed neurodegeneration and increases damage by sublethal ischemia in hippocampal CA1 and CA3 neurons J. Neurosci. 19 1999 9218 9227
26. A.V. Paternain, M. Morales, and J. Lerma Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons Neuron 14 1995 185 189
27. L. Pei, Y. Li, G.Y. Zhang, Z.C. Cui, and Z.M. Zhu Mechanisms of regulation of tyrosine phosphorylation of NMDA receptor subunit 2B after cerebral ischemia/reperfusion Acta. Pharmacol. Sin. 21 2000 695 700
28. D.S. Pei, Y.F. Sun, Q.H. Guan, Z.B. Hao, T.L. Xu, and G.Y. Zhang Postsynaptic density protein 95 antisense oligodeoxynucleotides inhibits the activation of MLK3 and JNK3 via the GluR6•PSD-95•MLK3 signaling module after transient cerebral ischemia in rat hippocampus Neurosci. Lett. 367 2004 71 75
29. W.A. Pulsinelli, and J.B. Brierley A new model of bilateral hemispheric ischemia in the unanesthetized rat Stroke 10 1979 267 272
30. R. Sattler, Z. Xiong, W.Y. Lu, M. Hafner, J.F. MacDonald, and M. Tymianski Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein Science 284 1999 1845 1848
31. A. Savinainen, E.P. Garcia, D. Dorow, J. Marshall, and Y.F. Liu Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling cascades via post-synaptic density protein 95 J. Biol. Chem. 276 2001 11382 11386
32. P.H. Seeburg The molecular biology of mammalian glutamate receptor channels Trends Neurosci. 16 1993 359 365
33. S.Y. Seo, B.S. Yun, I.J. Ryoo, J.S. Choi, C.K. Joo, S.Y. Chang, J.M. Chung, S. Oh, B.J. Gwag, and I.D. Yoo Complestatin is a noncompetitive peptide antagonist of N-methyl-d-aspartate and alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death J. Pharmacol. Exp. Ther. 299 2001 377 384
34. A. Tabernero, B. Granda, A. Medina, L.I. Sanchez-Abarca, E. Lavado, and J.M. Medina Albumin promotes neuronal survival by increasing the synthesis and release of glutamate J. Neurochem. 81 2002 881 891
35. H. Tian, Q. Zhang, H. Li, and G. Zhang Antioxidant N-acetylcysteine and AMPA/KA receptor antagonist DNQX inhibited mixed lineage kinase-3 activation following cerebral ischemia in rat hippocampus Neurosci. Res. 47 2003 47 53
36. H. Tian, G. Zhang, H. Li, and Q. Zhang Antioxidant NAC and AMPA/KA receptor antagonist DNQX inhibited JNK3 activation following global ischemia in rat hippocampus Neurosci. Res. 46 2003 191 197
37. T.A. Verdoorn, T.H. Johansen, J. Drejer, and E.O. Nielsen Selective block of recombinant glur6 receptors by NS-102, a novel non-NMDA receptor antagonist Eur J. Pharmacol. 269 1994 43 49
38. P.F. White, W.L. Way, and A.J. Trevor Ketamine-Its pharmacology and therapeutic uses Anesthesiology 56 1982 119 136
39. T.J. Wilding, and J.E. Huettner Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines Mol. Pharmacol. 47 1995 582 587
40. Y. Yamada, Y. Chochi, K. Takamiya, K. Sobue, and M. Inui Modulation of the channel activity of the epsilon2/zeta1-subtype N-methyl d-aspartate receptor by PSD-95 J. Biol. Chem. 274 1999 6647 6652
41. D.D. Yang, C.Y. Kuan, A.J. Whitmarsh, M. Rincon, T.S. Zheng, R.J. Davis, P. Rakic, and R.A. Flavell Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene Nature 389 1997 865 870
42. H. Zhang, and K.A. Gallo Autoinhibition of mixed lineage kinase 3 through its Src homology 3 domain J. Biol. Chem. 276 2001 45598 45603
43. G.J. Zipfel, D.J. Babcock, J.M. Lee, and D.W. Choi Neuronal apoptosis after CNS injury: the roles of glutamate and calcium J. Neurotrauma 17 2000 857 869